Company:  EMMAUS LIFE SCIENCES, INC ... (EMMA)
Form Type:  4
Filing Date:  6/23/2020 
CIK:  0000822370 
Address:  21250 HAWTHORNE BOULEVARD, SUITE 800 
City, State, Zip:  TORRANCE, California 90503 
Telephone:  310-214-0065 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$1.29  
Change: 
0.09 (7.50%)  
Trade Time: 
02:40 PM EST  
Market Cap: 
$63.19M
Trade EMMA now with 

© 2021  
Description of Business
In this Annual Report, the terms, "we," "us," "our" or the "Company" refer to Emmaus Life Sciences, Inc., and its subsidiaries. As reported in more detail in our Current Report on Form 8-K filed with the SEC on July 22, 2019, as amended by our Form 8-K/A filed on August 14, 2019, on July 17, 2019, we completed our merger transaction with EMI Holding, Inc., formerly known as Emmaus Life Sciences, Inc. ("EMI"), in accordance with the terms of the Agreement and Plan of Merger and Reorganization, dated as of January 4, 2019, among us, Athena Merger Subsidiary, Inc., and EMI, as amended by Amendment No. 1 thereto, dated as of May 10, 2019, which we refer to as the merger agreement. Pursuant to the merger agreement, Athena Merger Subsidiary, Inc. merged into EMI, with EMI surviving as our wholly owned subsidiary. On July 17, 2019, immediately after completion of the merger, we changed our name to "Emmaus Life Sciences, Inc.
Register and access this filing in:     
  FORM 4
    NAME AND TITLE
    NON DERIVATIVE SECURITIES
    DERIVATIVE SECURITIES
    EXPLANATIONS AND REMARKS
    REPORTING OWNERS
    SIGNATURES